Build A More Robust Model To Support Local Pharmacovigilance And Medical Information Activity

By Alisa Hummings, Senior Director and Head of Medical Information and Local AE Intake Services, and Simon Johns, Director, Medical Information and Marketed Product Safety

From the bird’s-eye perspective of a global pharmaceutical manufacturing organization, navigating the ins and outs of pharmacovigilance (PV), medical information (MI), and regulations at the local country level may seem overwhelming. When operating a global conglomerate, it is vital to develop scalable, robust strategies that can be standardized while still adhering to local health authority requirements. The question at the forefront of this challenge is, How do we effectively streamline our processes without breaking the budget?

To start, you must develop an understanding of your local country landscape, including legislation and current industry trends. This might be achieved via several strategies, including collaboration with an outsourcing partner that can build out your repertoire to include such offerings as local qualified persons for pharmacovigilance (QPPVs) to liaise with health authorities. There is also an expanding array of technology available to help make your MI processes more efficient and customer friendly. Download the full white paper to determine the potential gaps in your team’s solutions, examine current trends in the industry, and see how others are responding.